Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Jun 2026 to Jun 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v18
  2. Primary and study completion dates: Jun 2025 to Jun 2026v17
  3. Primary and study completion dates: Jun 2024 to Jun 2025v16
  4. Primary and study completion dates: Jun 2023 to Jun 2024v15
  5. Primary and study completion dates: Jun 2022 to Jun 2023v14
Show 12 earlier versionsHide 12 earlier versions
  1. Primary and study completion dates: Jun 2021 to Jun 2022v13
  2. Re-verified, no change to tracked fieldsv12
  3. Primary and study completion dates: Jun 2019 to Jun 2021v11
  4. Primary endpoint revised
    • Eligibility criteria expanded, about 10 words
    • Study title shortened, about 2 words
    v10
  5. Primary and study completion dates: Jun 2018 to Jun 2019v9
  6. Primary and study completion dates: Jun 2017 to Jun 2018
    • Site contact updated
    v8
  7. Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI) to University of Pennsylvania
    • Primary completion date: Jun 2017
    • Study completion date: Feb 2012 to Jun 2017
    • Collaborators: 9 to 10
    v7
  8. Collaborators: 8 to 9v6
  9. Study completion date: Feb 2011 to Feb 2012v5
  10. Re-verified, no change to tracked fieldsv4
  11. Study completion date: Feb 2011v3
  12. Study description revisedv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Primary graft dysfunction (PGD) is a severe lung injury that can occur in the days following lung transplant surgery. The purpose of this study is to identify genetic factors that may put someone at risk for developing PGD.
Trial Details
NCT Number NCT00457847
Lead Sponsor University of Pennsylvania
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Columbia University, Vanderbilt University, Stanford University, University of Alabama at Birmingham, University of Michigan, Johns Hopkins University, Duke University, University of Pittsburgh, University of Chicago
Conditions
(from sponsor)		 Primary Graft Dysfunction, Lung Transplantation
Related terms Primary Graft Dysfunction
Enrollment 1,150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov